Researchers develop reovirus vaccine for turkeys

Turkey arthritis reovirus causes lameness and hepatitis in turkeys.

USPOULTRY and the USPOULTRY Foundation are announcing the completion of a funded research project, aimed at developing six vaccines for reovirus in turkeys, by researchers in the Department of Veterinary Population Medicine at the University of Minnesota. Made possible by an endowing USPOULTRY Foundation gift from West Liberty Foods, the research is part of USPOULTRY's comprehensive research program encompassing all poultry and egg production and processing phases.

The project, titled " Development of Live Attenuated Vaccine for Reoviruses Causing Arthritis and Hepatitis in Turkeys," was led by Dr. Sagar Goyal, Veterinary Population Medicine, University of Minnesota.

Turkey arthritis reovirus causes lameness and hepatitis in turkeys, resulting in huge economic losses and can also lead to welfare concerns. Goyal and colleagues aimed to develop live attenuated vaccines that could provide broad protection against turkey arthritis reoviruses and turkey hepatitis reoviruses. The six vaccines developed in the study indicated they were safe to use in turkey poults. However, a single dose of the developed vaccines in 10-day-old poults was insufficient to protect against the disease.

Source: U.S. Poultry & Egg Association

You must login or register in order to post a comment.

On-Demand Join us for an exclusive look into the future of the protein industry with The National Provisioner’s 2024 State of the Industry webinar, a key feature of our October eMagazine. Dive deep into transformative insights as consumer research experts from Circana take the stage.

IPPE 2025

The International Production & Processing Expo is the world's largest annual poultry and egg, meat, and animal food industry event of its kind. A wide range of domestic and international decision-makers attend this annual event to find solutions for their business, network with industry colleagues, and learn about the latest technological developments and issues facing the industry.

The 2025 IPPE already has 1,200+ exhibitors that will occupy more than 583,000+ square feet of exhibit space. The 2025 IPPE will offer timely and important information and an efficient way for producers and processors to find solutions to enhance their operations.

We look forward to being with you again at the Georgia World Congress Center in Atlanta. Mark your calendar to join us Jan. 28 - 30, 2025. You will not want to miss this "must-attend" event for our industries!